Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin. (2022)
Attributed to:
Understanding human cytomegalovirus latency as a means to target the latent reservoir
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.healun.2021.10.010
PubMed Identifier: 34802874
Publication URI: http://europepmc.org/abstract/MED/34802874
Type: Journal Article/Review
Volume: 41
Parent Publication: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Issue: 3
ISSN: 1053-2498